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Ameloblasts produce enamel matrix proteins such as amelogenin, ameloblastin, and amelotin during tooth development. The
molecular mechanisms of ameloblast diﬀerentiation (amelogenesis) are currently not well understood. SP6 is a transcription
factor of the Sp/KLF family that was recently found to regulate cell proliferation in a cell-type-specific manner. Sp6-deficient mice
demonstrate characteristic tooth anomalies such as delayed eruption of the incisors and supernumerary teeth with disorganized
amelogenesis. However, it remains unclear how Sp6 controls amelogenesis. In this study, we used SP6 high producer cells to identify
SP6 target genes. Based on the observations that long-term culture of SP6 high producer cells reduced SP6 protein expression
but not Sp6 mRNA expression, we found that SP6 is short lived and specifically degraded through a proteasome pathway. We
established an in vitro inducible SP6 expression system coupled with siRNA knockdown and found a possible linkage between SP6
and amelogenesis through the regulation of amelotin and Rock1 gene expression by microarray analysis. Our findings suggest that
the regulation of SP6 protein stability is one of the crucial steps in amelogenesis.
1. Introduction
Specificity Protein 6 (Sp6), also known as epiprofin, is a
member of the SP/KLF transcription factor family [1–3]. Sp6
mRNA is expressed in dental epithelial cells during tooth
development [3], and SP6 protein has been detected in the
ameloblast layer of rat incisors accompanied by amelogenin
expression [4]. The presence of two transcripts of Sp6 has
been reported due to alternative promoter usage with tissue-
and developmental stage-specific regulation, resulting in
connections of two diﬀerent first exons (epiprofin exon 1 and
Sp6 exon 1) with the same second exon, which contains the
coding region [3, 5]. However, we have recently reported that
both transcripts are present in the same developmental stage
in dental epithelial cells, demonstrating that the Sp6 gene
comprises two first exons (exon 1a and exon 1b) as well as
a second exon [6].
Two other research groups have developed Sp6-deficient
mice to explore the function of SP6 in vivo, and they
have reported several tooth abnormalities, including delayed
eruption of incisors, supernumerary teeth, and enamel
disorganization [7, 8]. We established a gain-of-function
system in vitro and found that SP6 inhibits follistatin (Fst)
gene expression in dental epithelial cells [4]. These findings
show that Sp6 is indispensable for tooth development.
However, the molecular basis for the biological functions of
SP6 remains unclear.
In this study, we found that SP6 is a short lived protein
that is specifically degraded via a proteasome pathway.
Based on these findings, we established an in vitro SP6
induction system using a proteasome inhibitor, MG132,
in combination with a small interfering RNA (siRNA)
knockdown technique. The system sharply distinguished the
presence or absence of SP6 protein in dental epithelial cells
with the same genetic background. Taking advantage of this
system, we screened SP6 target genes by DNA microarray
analysis. Identification of amelotin (Amtn) and Rock1 (Rho-
associated coiled-coil containing protein kinase 1) among the
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target genes suggested a specific role of SP6 in amelogenesis,
providing a molecular basis for the direct link between SP6
function and tooth development.
2. Material and Methods
2.1. Sp6 High Producer C9 Cells. SP6 high producer cells,
CHA9 cells, were previously established as a stable trans-
formant clone [4], originating from the rat dental epithelial
derived ameloblast-lineage clone, G5 [9]. G5 cells are a
cloned cell derived from a rat enamel organ-derived dental
epithelial sheet, expressed amelogenin mRNA, but not its
protein [9]. CHA9 cells were recloned by serial limiting
dilutions in the presence of G418 (400 µg/mL: Nakalai
Tesque, Kyoto, Japan), and C9 cells, the clone with the
highest production of SP6, were selected by Western blot
analysis (WB). The cells were maintained in a combination
of Dulbecco’s modified Eagle’s medium/Ham’s F12 medium
(D/F12, Nissui, Tokyo, Japan) supplemented with 10% foetal
bovine serum (FBS, JRH Biosciences, Lenexa, Kan, USA).
2.2. Western Blot Analysis (WB). Protein lysates were ob-
tained by dissolving the cells in 2× sodium dodecyl sulfate
(SDS) sample buﬀer, as described previously [4]. Protein
concentration was measured using the BCA Protein Assay
Kit (Pierce, Rockford, Ill, USA). Thirty µg of total pro-
tein were loaded on 10% SDS-polyacrylamide gels (SDS-
PAGE). After electrophoresis, proteins were transferred to a
polyvinylidene difluoride (PVDF) membrane (Immobilon;
Millipore, Bedford, Mass, USA) and blocked with 5% skim
milk in tris-buﬀered saline (TBS) (10mM Tris-HCl [pH
8.0], 150mM NaCl) with 0.05% Tween-20 for 3 h at room
temperature (RT). The membranes were incubated with
anti-HA antibody (1 : 5000; Santa Cruz Biotechnology, Santa
Cruz, Calif, USA) overnight at 4◦C, and immunodetec-
tion was performed using the same procedure described
previously [4]. Quantification analysis was performed by
densitometric scanning with “Quantity One” software (Bio-
Rad laboratories, Hercules, CA, USA) according to the
manufacturer’s instructions. Lysates of Cos7 cells transfected
with the CHA-Sp6 in pCIneo were used as a positive control
if not specified.
2.3. Reverse Transcription-PCR (RT-PCR) and Quantitative
PCR Analysis. Total RNA was purified using TRI Reagent
(Molecular Research Center. Inc., Cincinnati, Ohio, USA)
according to themanufacturer’s instructions. After treatment
with DNase I (Invitrogen, Carlsbad, Calif, USA), 500 ng
of total RNA were converted into cDNA using an RNA
PCR kit AMV Ver. 3.0 (Takara, Shiga, Japan) according
to the manufacturer’s instructions. Synthesized cDNA was
subjected to either PCR analysis using Taq DNA polymerase
(Promega, Madison, Wis, USA) or quantitative PCR (qPCR)
using Thunderbird SYBR qPCR Mix (Toyobo Co. Ltd.,
Osaka, Japan). Gene-specific primer sets are shown in
Table 1. qPCR was performed with a 7300 Real-Time PCR
System (Applied Biosystems, Carlsbad, Calif, USA). The
expression ratios were calculated from the threshold cycles
Table 1: Gene-specific primers.
Gene Primer sequence
Amelotin
5′-CCTCCTTATCCACCCCTTG-3′
5′-CCAACTGTGATGTGGTTTGC-3′
Car3
5′-CCTCTCTCTGGACCCTACC-3′
5′-TTTTGTCCAGGGCATCAAGG-3′
Follistatin
5′-TTTTCTGTCCACCGGCAGCTCCAC-3′
5′-GCAAGATCCGGAGTGCTTCACT-3′
Osr2
5′-ATTCACGAGAGGACCCACAC-3′
5′-GTTTCGCCTGAACACTTTGC-3′
Pcm1
5′-CTTGGGTGGCATCAAACTCC-3′
5′-CCAAGTGAATCACGGTGTTG-3′
Rock1
5′-GGATGCTACCTGATCACCAG-3′
5′-CCGTAGGCAAACCCGCAAG-3′
Sp6 cds
5′-CCGGCAATGCTAACCGCTGTCTGTG-3′
5′-GGCTCAGTTGGAGGACGCCGAGCTG-3′
Sp6
endogenous
5′-GCGCCATCTTCAGACCCAC-3′
5′-CCACTTCGCAAGAGGATTTC-3′
Sp6
exogenous
5′-GGCTAGAGTACTTAATACGACTCAC-3′
5′-CTCGAAGCATTAACCCTCACTAAAG-3′
18s rRNA
5′-TACCTGGTTGATCCTGCCAGTAGGAT-3′
5′-CCCGTCGGCATGTATTAGCTCTAGAA-3′
and normalized to 18s rRNA results. All data were confirmed
by triplicate experiments.
2.4. SP6 Protein Stability and Half-Life. For lysosomal analy-
sis, C9 cells were treated with or without 1, 3, 10, and 20mM
of ammonium chloride (NH4Cl: Wako Pure Chemical
Industries, Ltd. Osaka, Japan) at 7 and 24 h. For proteasomal
analysis, Cbz-leu-leu-leucinal (MG132: Calbiochem, EMD
Chemicals, Inc., San Diego, Calif, USA) or acetyl-leu-leu-
norleucinal (ALLN: Calbiochem, EMD Biosciences Inc.) was
applied to C9 cells. To investigate dose-dependent eﬀects, C9
cells were treated with 0.3 and 10 µM of MG132 or 5, 10,
and 15 µM of ALLN for 7 h. To analyze protein stability,
cycloheximide (CHX; Wako Pure Chemical Industries, Ltd.
Osaka, Japan) was used as described previously [10]. In
brief, C9 cells were preincubated with 10 µM of MG132
for 8 h and washed with PBS(−) (137mM NaCl, 8.1mM
Na2HPO4·12H2O, 2.68mM KCl, 147mM KH2PO4, [pH
7.4]) twice. The medium was then replaced with fresh
medium, and 10mM CHX was added either alone or
together with MG132. The cells were harvested at the
indicated time points, and the cell lysates were used for WB.
2.5. 20S Proteasome Activity. A 20S proteasome activity
assay kit (Cayman Chemical Company, Ann Arbor, MI,
USA) was used to analyze proteasome activity in accordance
with the manufacturer’s protocol. In brief, G5 and C9
cells at passage 7 (P7) and P28 were prepared with or
without MG132 treatment for 8 h. Each cell preparation was
transferred into individual tubes with 1 × 105 cells. The
cells were then washed with 20S proteasome assay buﬀer.
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Table 2: Antibody information.
Antigen (clone) Company Code number Dilution (WB) Dilution (IC)
HA-tag (Y-11) Santa Cruz biotechnology sc-805 1 : 5000 1 : 250
HA-tag (3F10) Roche #867423001 1 : 1000 1 : 250
Ubiquitin DAKO Z0458 1 : 4500 —
Sumo1 (FL-101) Santa Cruz biotechnology sc-9060 1 : 1000 —
Sumo1 Cell signalling #4930 1 : 1000 —
Sumo2/3 (18H8) Cell signalling #4971 1 : 1000 —
(Santa Cruz biotechnology, Inc., Santa Cruz, Calif, USA; DAKO, Glostrup, Denmark; Cell signalling, Danvers, Mass, USA).
After centrifugation for 5min at 500 g, the supernatant
was aspirated. One hundred µL of 20S Proteasome Lysis
buﬀer was added to the pellet and incubated at RT for
30min. After centrifugation for 10min at 1,000 g, 90 µL of
the supernatant was transferred to a black 96-well detection
plate. After 10 µL of buﬀer or control inhibitor solution
was added to each well, 10 µL of substrate (Suc-LLVY-
AMC) solution was added. The plate was then incubated
for 1 h at 37◦C. The fluorescent intensity of each well
(excitation at 360 nm; emission at 480 nm) was analysed
with Varioskan Flash (Thermo scientific, Waltham, Mass,
USA) and SkanIt Software (Thermo scientific) according
to the manufacturer’s instructions. All experiments were
performed in triplicate.
2.6. Immunocytochemistry (IC). C9 cells were seeded in a 12-
well plate. After treatment for 8 h with or without 10 µM
MG132, the cells were washed with PBS(−) once. The cells
were then fixed with 100% ethanol for 10min at RT. After
washing 3 times with PBS(−), the cells were permeabilized
with 0.2% Triton X-100 in PBS(−) for 15min at RT, then
blocked with 4% BSA in PBS(−) for 30min at RT. They were
then incubated with HA-tagged antibody (1 : 250 dilution;
Santa Cruz Biotechnology) overnight at 4◦C. The next day,
the cells were washed with PBS(−) 3 times and incubated
with Alexa 594 anti-rabbit IgG (1 : 500 dilution; Molecular
Probes, Eugene, Ore, USA) and 1 µg/mL Hoechst 33342 for
45min at RT. After washing the cells 3 times with PBS(−),
the wells were filled with PBS(−), and the plate was analysed
by fluorescence microscopy (Table 2).
2.7. Knockdown of Sp6 by siRNA Transfection. Twenty-five
nM of Stealth RNAi siRNA for Sp6 (Sp6 siRNA; Invitrogen)
or Stealth RNAi siRNA Negative Control Duplex Med GC
#2 (GC; Invitrogen) was transfected into C9 cells at 30%
confluency at P28 in a 12-well plate using Lipofectamine
RNAiMAX (MAX; Invitrogen) for 24 or 48 h; the cells were
then harvested. Ten µM of MG132 was added 8 h before
harvesting the cells (i.e., the cells were subjected to 8 h of
treatment with MG132).
2.8. Microarray Analysis. Total RNA was isolated from
Sp6 siRNA-MG132- or GC-MG132-treated C9 samples
using TRI Reagent. Purity was examined using an Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara, Calif,
USA). Microarray analysis was performed using GeneChip
Rat Gene 1.0 ST Arrays (Aﬀymetrix, Santa Clara, Calif,
USA). This microarray chip contains 27,342 oligonucleotides
probes for known and unknown genes. First-strand cDNA
was synthesized from 300 ng of total RNA using a WT
Expression Kit (Aﬀymetrix) according to the manufacturer’s
instructions. Ten µg of cRNA was added to the second-cycle
cDNA reaction. cDNA was fragmented and end-labelled
with a GeneChip WT Terminal Labeling Kit (Aﬀymetrix).
Approximately 5.5 µg of fragmented and labelled DNA target
was hybridized to the array for 17 h at 45◦C in a GeneChip
Hybridization Oven 640 (Aﬀymetrix) in accordance with the
manufacturer’s recommendations. Hybridized arrays were
washed and stained on a GeneChip Fluidics Station 450 and
scanned with a GeneChip Scanner 3000 7G (Aﬀymetrix),
and a CEL file was generated for each array. The data
were analysed with GeneSpring GX11.0 (Silicon Genetics,
Redwood City, Calif, USA). Expressed genes that showed
fluorescence intensity greater than 100 were further analysed.
Genes with more than a 2-fold diﬀerence between the
Sp6 siRNA-treated samples and negative controls were
selected.
2.9. Statistics. The immunoprecipitation, Western blot anal-
yses, 20S proteasome activity, and qRT-PCR data presented
are representative of three independent analyses conducted
under the same experimental conditions. Determination of
the half-life of the SP6 protein was conducted twice using
individual analyses under the same experimental conditions.
The data reported reflect the means ± S.D. of triplicate
samples from the representative experiments. Student’s t-test
was utilized for proteasome activity by Microsoft Exel for
Mac 2008 (Redmond, Wash, USA).
3. Results
3.1. SP6 Expression during Long-Term Culture. In a previous
study, we established Sp6 stable transformants, CHA9 cells
[4], using the dental epithelial clone, G5 cells [9]. However,
we found that the level of SP6 was reduced in CHA9
cells during long-term culture. To investigate the molecular
nature and function of SP6, we recloned a new SP6 high
producer clone from CHA9 cells, C9 cells. Unexpectedly,
by WB, we again found a significant reduction in the SP6
expression level in C9 cells at P28 compared with strong
SP6 expression at P7 (Figure 1(a)). In contrast, as shown
in Figure 1(b), the level of Sp6 mRNA cds, which detects
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Figure 1: Downregulation of SP6 in C9 cells during long-term
culture. (a) SP6 expression in C9 cells (P7 and P28) and in parent
G5 cells. SP6 protein levels were analysed by WB using anti-
HA antibody. Arrow: SP6; asterisk: nonspecific band and Posi:
positive control. (b) Sp6 mRNA expression in C9 cells (P7 and
P28) and G5 cells. Upper panel indicates schematic structure of the
Sp6 gene and expression plasmid together with primer positions.
Primers designed to detect three distinct types of Sp6 mRNA.
Arrows indicate each primer’s position and direction. Grey box:
untranslated region; striped box: HA-tag; cds: coding region of
Sp6; endo: endogenous Sp6; exo: exogenous Sp6. Middle panel
shows the representative result of RT-PCR analysis. Lower panel
shows densitometric analysis data of RT-PCR. Each Sp6 level was
normalized by 18S rRNA level, and the relative ratio was calculated
compared to that of G5 cells. The level of G5 cells was assigned as
one.
the coding regions derived from both endogenous and
exogenous Sp6 mRNA, was about 3.2-and 2.2-fold higher
at P7 and P28, respectively, compared to that of the parent
G5 cells. The polygonal epithelial cell-like morphology and
growth rate were kept in C9 cells at P7 and P28. Based on
these findings, we assumed that the stability of SP6 protein is
involved in the regulation of SP6 expression.
3.2. Analysis of SP6 Stability. To explore the cause of the
reduction of SP6 protein expression in C9 cells at P28, we
examined two major pathways of protein degradation in
the cells: the proteasome and lysosomal pathways [11, 12].
We first tested whether the lysosomal inhibitor NH4Cl had
any eﬀect on the inhibition of SP6 protein degradation. As
shown in Figure 2(a), we could not detect any enhancement
or induction of SP6 expression by NH4Cl at P7 or P28;
rather we found an acceleration of its reduction due to cell
toxicity at higher concentrations. Next we examined the
eﬀects of a proteasome inhibitor, MG132, on SP6 protein
expression in C9 cells. In contrast to NH4Cl, C9 cells treated
with 0.3 and 10 µM of MG132 for 7 h showed remarkably
enhanced levels of SP6 protein expression at P7 and P28
in a dose-dependent manner (Figure 2(b), upper panel). C9
cells treated with another proteasome inhibitor, ALLN, also
showed dose-dependent enhanced SP6 protein expression,
although the optimal dose was diﬀerent between P7 and P28
(Figure 2(b), lower panel). We further examined the eﬀect
of time course of MG132 treatment on SP6 expression. SP6
protein expression was gradually increased from 2 to 12 h
after the addition of 10 µM MG132 to the culture, and more
than 85% of maximal enhancement was obtained by 8 h
of treatment, followed by a peak up to 68-fold increase at
12 h (Figure 2(c)). To prove the proteasome activity in dental
epithelial cells, we measured the 20S proteasome activity in
C9 cells at P7 and P28 as well as in the parent G5 cells. C9
at P28 and G5 cells had the similar levels of 20S proteasome
activity (n = 3, P > 0.01). C9 at P28, proteasome activity
became 67% of P7 (n = 3, P < 0.01). We also observed
that G5 cells have statistically higher activity compared to
that of Jurkat cells (n = 3, P < 0.01), which are a positive
control with high 20S proteasome activity provided in a
kit (Figure 2(d)), indicating a possible role of proteasome
activity in dental epithelial function.
We next analysed the stability of SP6 protein in C9 cells
at P28 to determine whether SP6 is a short lived protein.
C9 cells were cultured with 10mM CHX in the presence
or absence of MG132 as described in the experimental
section. As shown in Figure 2(e), regardless of whether
MG132 was retained continuously or refreshed, MG132
treatment maintained a similar SP6 level. When we changed
the medium to wash out MG132, the level of SP6 was rapidly
reduced to 25% of that of the peak within 1 h (Figure 2(e)).
The half-life of the SP6 protein (t1/2) was assessed to be
approximately 40min. These results demonstrated that the
SP6 protein is actually a short lived protein and is rapidly
degraded through a proteasome pathway in dental epithelial
cells.
3.3. In Vitro Regulation of SP6 Expression in Combination
with MG132 Treatment and siRNA Knockdown. Although
a proteasome inhibitor, MG132, could markedly induce
and stabilize SP6 protein levels in C9 cells, it was not
clear whether MG132-induced SP6 were able to function
as a transcription factor. To address this question, we first
examined the localization of the SP6 protein in MG132-
treated C9 cells at P28 by immunocytochemical analysis.
As shown in Figure 3(a), distinct SP6 signals was detected
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Figure 2: Eﬀects of protease inhibitors on SP6 expression level in C9 cells. (a) Dose-dependent eﬀects of the lysosomal inhibitor, NH4Cl,
on SP6 expression in C9 cells. The SP6 expression level was evaluated by WB. Posi: positive control; N: no treatment. (b) Dose-dependent
eﬀects of MG132 on SP6 expression in C9 cells. Upper panel: the cells were treated with MG132 (M) or DMSO (D) as a control (vehicle
alone) for 7 h. Lower panel: cells were treated with ALLN (A) or DMSO (D) for 7 h. Posi: positive control; N: no treatment; arrow: SP6;
asterisk: nonspecific band. (c) Time course of the eﬀects of MG132 treatment on SP6 induction in C9 cells. C9 cells at P28 were treated with
10 µM MG132 during the indicated time. Upper panel: SP6 expression analysed by WB; Posi: positive control. Lower panel: Relative levels of
signal intensity of WB. Each SP6 level was shown as the relative level compared with the signal detected at 12 h (100%). (d) 20S proteasome
activity in G5 and C9 cells (P7 and P28). J: Jurkat cells (positive control). The brackets show the significant diﬀerence demonstrated by
Student’s t-test (n = 3, ∗P < 0.01). (e) Half-life analysis of SP6 in C9 cells at P28 determined by blocking de novo protein synthesis. C9 cells
were pretreated with MG132 for 8 h, and then 10 µg/mL CHX was added during the indicated time. Upper panel: SP6 expression detected
by WB; Retained: no medium change (MG132 was retained) when CHX was added; Refreshed: new medium replaced the old medium,
and MG132 was newly added to the culture with CHX; Eliminated: the medium was replaced without MG132, only CHX was added; Posi:
positive control; N: untreated C9 cells. Upper panel: relative SP6 expression level ratios. Each signal level was normalized with that at time 0
(100%). Data were reproduced by two independent experiments.
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Figure 3: Specificity of SP6 induction by MG132 treatment. (a)
Subcellular localization of SP6 in C9 cells treated with MG132.
SP6 localization was analysed by immunofluorescence signals. Red
colour indicates SP6 detected by anti-HA antibody, blue colour
shows nuclei stained with Hoechst 33342. (a–d): low magnification;
(e–h): high magnification. Scale bar indicates 200 µm. (b) Knock-
down of SP6 in MG132-treated C9 cells by siRNA. Posi: positive
control; N: no treatment; M: Lipofectamine RNAiMAX only; GC:
negative control siRNA; si: siRNA against Sp6. Upper panel: SP6
expression was detected by WB. Lower panel: relative SP6 levels
estimated by densitometric analysis of WB results.
mainly in the nuclei of MG132-treated C9 cells and were
detected hardly at all in untreated cells. Nuclear localization
of SP6 was the same as native SP6 observed in vivo [4]. Next,
to check whether MG132-induced SP6 could regulate the
gene expression, we examined RT-PCR analysis of Fst mRNA
since we previously demonstrated that it is specifically down-
regulated by SP6 (4). We confirmed the downregulation of
Fst mRNA in MG132-treated C9 cells (data not shown),
indicating that MG132-induced SP6 protein can act as a
transcription factor. These findings prompted us to further
analyze the SP6 target genes using an MG132-mediated
SP6 induction system in C9 cells. This is great advantage
to analyze SP6 functions in one cell line, in other words,
with the same genetic background. Because when we simply
compared transformant C9 cells with parental G5 cells, we
cannot eliminate the influences upon gene expression due to
the genomic insertion of transgene into C9 cells compared to
parental G5 cells.
To establish the specified SP6 induction system, we first
checked the feasibility of in vitro MG132-mediated SP6
induction combined with siRNA knockdown to eliminate
the dosage eﬀect of Sp6 gene. As shown in Figure 3(b),
SP6 expression was completely inhibited in C9 cells treated
with Sp6-specific siRNA for both 24 h and 48 h compared
with control siRNA (GC-) treated cells. In addition, we
observed that C9 cells treated with siRNA for 48 h produced
approximately 25% of the SP6 protein level at 24 h. Since the
SP6 protein level in GC-treated cells was comparable with
that in untreated cells (N) as well as that in the cells treated
with transfection reagent (M) at 48 h, this reduction was not
caused by reagent toxicity. These results confirmed that the in
vitroMG132-mediated SP6 induction system combined with
siRNA was a reliable experimental procedure for detecting
transcriptional target genes.
3.4. Identification of Sp6 Target Genes by Microarray Anal-
ysis. To find out the tissue-specific function of SP6 as a
transcription factor in dental epithelial cells, we performed
microarray analysis using the in vitro MG132-mediated SP6
induction system to compare SP6 siRNA-treated samples
and the control siRNA (GC) samples shown in Figure 3(b)
at 24 h and 48 h. Among 27,342 probes on the array, 74
(known genes: 47; unknown genes: 27) and 310 genes
(known genes: 190; unknown genes: 120) were regulated
by SP6 presence or absence at 24 h and 48 h, respectively
(Figure 4(a)). Twenty-one genes were commonly regulated
among the 24 and 48 h-treated samples, 17 of which are
known genes. Among these, we found several potential
amelogenesis-related genes, including Amtn [13], Rock1 [14]
and Car3 (carbonic anhydrase 3) [15] among all samples, Fst
[4] in the 24 h group of samples, and Pcm1 (pericentriolar
material 1) [16] and Osr2 (Odd-skipped 2) [17] in the 48 h
group of samples. As shown in the right panel of Figure 4(a),
the Amtn, Pcm1, and Rock1 genes were positively regulated,
and the Fst, Car3, and Osr2 genes were negatively regulated,
by the presence of SP6 protein. To validate the microarray
data, we further analysed mRNA levels of these genes in C9
cells by qPCR analysis. The relative mRNA levels from the
microarray and qPCR results correlated well (Figure 4(b)).
Both the Amtn and Pcm1 genes were increased 8-9-fold at
48 h compared with 24 h, while the level of Rock1 mRNA
was similar between the two time points. On the other hand,
the Fst, Car3, and Osr2 genes were all reduced to 20%–50%
of the original level at 48 h compared with 24 h. To further
confirm the specificity of the relationship between SP6
protein expression and target gene response, we examined
Amtn and Rock1 mRNA expression in C9 cells at P7 and P28.
The expression of Amtn and Rock1 mRNAs was significantly
downregulated at P28 to 4.5% and 30%, respectively, of that
at P7 (Figure 4(c)). These data clearly demonstrated that the
stabilization of the SP6 protein regulates the expression of the
target genes in dental epithelial cells.
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Figure 4: Screening of Sp6 target genes by microarray. (a) Venn diagram showing a summary of microarray data; the number of genes
that was changed more than 2-fold between the SP6 producing sample (GC: negative control of siRNA) and the SP6 knockdown sample
(siRNA of SP6) is also indicated. Numbers with brackets are unknown genes and those without brackets are known genes. The right panel
indicates that the expression levels of tooth-related genes were normalized using a control (GC) based on microarray data. (b) Confirmation
of microarray data by qPCR. The fold changes were calculated and compared to that of 24 h control (GC 24; 100%). GC: negative control
siRNA; si: siRNA against Sp6. All experiments were performed in triplicate. (c) The mRNA levels of the Amtn and Rock1 genes in C9 at P7
and P28. qPCR was performed with total RNA purified from C9 cells at P7 and P28 and normalized by the level of 18s rRNA. The levels of
Amtn and Rock1 mRNA expression at P7 are indicated as 100%.
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4. Discussion
Both loss- and gain-of-function studies have demonstrated
that Sp6 is indispensable during development of teeth, skin,
limbs, lungs, and so on. [4, 7, 8, 18]. However, little is known
about the molecular basis for the biological role of Sp6 [19].
In this study, we obtained two important findings relating to
SP6; one is its stability in nature, and the other is the potential
target genes during tooth development.
The first finding was that the SP6 protein level is finely
tuned by a ubiquitin-independent proteasome pathway in
dental epithelial cells. SP6 protein is a short lived molecule
(t1/2 = 40min, Figure 2(e)) similar to the immediate-early
gene product, c-Fos (t1/2 = 47min during G0/G1 transition
in Balb/C3T3 fibroblasts) [20]. Many transcription factors
are short lived proteins and are degraded via a proteasome
pathway [11], indicating that transcription factors are tightly
regulated to maintain homeostasis at specific diﬀerentiation
stages or tissue circumstances. Notably, the level of Sp6
mRNA was maintained at a similar level during long-term
culture, although SP6 protein expression was transiently
high during early cell passage and was maintained at a
low level during later passages (Figures 1(a) and 1(b)). 20S
proteasome activities in dental epithelial cells are constantly
high (Figure 2(d)); however, the underlying mechanisms
of transient SP6 expression during early passage remain
unclear.
In general, proteasome degradation is mediated by
ubiquitin-dependent or -independent pathways [21]. The
ubiquitin-dependent pathway is known to be initiated by
polyubiquitination or other posttranslational modifications,
such as sumoylation and phosphorylation of the target
proteins [22]. We found possible sites for these modifications
in the rat SP6 sequence; however, we could not detect any
modifications of SP6 (data not shown). It is quite interesting
issue to see how SP6 was stabilized in C9 cells at P7 but
not in C9 cells at P28 or in the parent G5 cells in relation
to proteasome regulation. A unique structural feature of
the SP6 protein among the Sp/KLF family is a proline-
rich sequence at the N-terminal half of the SP6 protein
[1, 2]. Since proline-rich sequences often form a protein-
protein binding interface [23], the binding partner(s) of
SP6 via this region could be involved in SP6 stability.
Further investigations are required for better understanding
of proteasome regulation of SP6 stability and its relationship
to SP6 protein binding partners.
The second important finding was the identification
of novel SP6 target genes linked with amelogenesis. We
first developed an in vitro MG132-mediated SP6 induc-
tion system combined with siRNA knockdown technology
(Figure 3). The most important feature of this in vitro system
is that it enables direct investigation of the downstream target
genes during SP6 functioning maintaining the same genetic
background. Taking advantage of this system, we screened
and identified potential target genes by microarray analysis.
We found 6 tooth-related genes, Amtn, Pcm1, Rock1, Fst,
Car3, and Osr2, which were regulated by the SP6 protein
(Figure 4).
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Figure 5: Proposed model of Sp6 expression and function coupled
with amelogenesis in dental epithelial cells. BMP and Wnt signals
can enhance Sp6 promoter activity, resulting in the enhancement
of Sp6 mRNA expression (6). The level of SP6 protein expression
is regulated by proteasome activity, which would be physiologically
controlled by aMG132-equivalent factor X. Stabilized SP6 protein is
transferred into the nucleus and regulates the expression of amelotin
and rock1 mRNA. BRE: BMP signal-responsive elements; WRE:
Wnt signal-responsive elements.
Among these, the Amtn gene was strikingly upregulated
by the presence of SP6 protein. The Amtn gene was recently
described as a novel ameloblast-specific gene [13, 24, 25],
and it is highly conserved in mammals; the rat Amtn gene
is located at chromosome 14p21 where it is quite close to
other ameloblast-specific genes, including ameloblastin and
enamelin at chromosome 14p22 [24, 25]. In addition, the
AMTN protein has been detected in the enamel matrix at the
postsecretory transition and maturation stage of ameloblasts
during enamel development [13, 24, 26], since SP6 protein
is expressed in the ameloblast layer from the presecretory
stage to the secretory stage in the enamel-forming region
[4], indicating a sequential expression pattern of SP6 and
AMTN. Another SP6 target gene in amelogenesis is Rock1,
a notable gene in amelogenesis. ROCK1 protein expression
is localized in the inner enamel epithelium in presecretory
throughmature ameloblasts and the stratum intermedium in
dental epithelial cells, regulating cell morphology, adhesion
to control cell proliferation and cell polarity [14, 27].
Altogether, SP6 functions, at least in part, through Amtn
or Rock1 regulation in amelogenesis. To the best of our
knowledge, this is the first report to demonstrate a molecular
connection between SP6 function and the late stage of
amelogenesis related genes. In Figure 5, we summarize our
current model of SP6 expression and its functional coupling
with amelogenesis, incorporating our present study with
previous observations [6, 18].
In conclusions, we found that SP6 protein is short
lived, and our in vitro SP6 induction system coupled
with microarray analysis identified novel ameloblast-specific
target genes. Our findings provide the molecular basis for
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the nature of the SP6 protein and its possible function as a
transcription factor in dental epithelial cells. Further studies
are required to analyze the tight regulation of both SP6
protein expression and stability during tooth development
to clarify the biological roles of SP6. Specially we have to
confirm direct binding of SP6 to the new target genes in this
system and endogenous system in vitro. Furthermore, to link
with in vivo function in amelogenesis, we need to establish
ameloblast diﬀerentiation system to mimic in vivo status,
for example, 3D culture or organ culture combined with
siRNA technology and observe the diﬀerentiation markers.
These issues may provide further hints in relation to the
developmental regulatory system and cellular physiological
homeostasis.
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